Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study "AFASAK II"

Completed

Phase 3 Results

Results

The cumulative rate of primary endpoint after 1 year was 5.8% in patients receiving minidose warfarin, 7.2% in patients receiving warfarin plus aspirin, 3.6% in patients receiving aspirin alone and 2.8% in patients receiving adjusted-rate warfarin. No difference was found between the groups after 3 years.